Effect of treatment on morning symptoms in COPD. Correlation between doctors and patients in the evaluation of symptoms. SINCON Study

A. Baloira Villar (Pontevedra, Spain), J. Trigueros (Toledo, Spain), J. Rodriguez Gozález-Moro (Alcalá de Henares, Spain), E. Sanjuan (Viladecans, Spain), R. Casamor (Barcelona, Spain)

Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Session: Patient-reported outcomes and scores in COPD
Session type: Thematic Poster
Number: 4007
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Baloira Villar (Pontevedra, Spain), J. Trigueros (Toledo, Spain), J. Rodriguez Gozález-Moro (Alcalá de Henares, Spain), E. Sanjuan (Viladecans, Spain), R. Casamor (Barcelona, Spain). Effect of treatment on morning symptoms in COPD. Correlation between doctors and patients in the evaluation of symptoms. SINCON Study. 4007

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of morning symptoms on COPD Management
Source: CME Online 2011
Year: 2005

Impact of nighttime and early morning symptoms on HRQoL and work productivity of COPD patients
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013


Evaluation of day and night symptoms in patients with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 208s
Year: 2001

GOLD assessment of COPD patients: Impact of symptoms assessment choice
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

Identification of COPD patient factors associated with nighttime and early morning symptoms
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013


Does the effectiveness of pulmonary rehabilitation vary in patients with different baseline severity of symptoms classified by MRC grade?
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013


Does the duration of symptoms pre admission influence the clinical course of the exacerbation in COPD?
Source: Eur Respir J 2004; 24: Suppl. 48, 15s
Year: 2004

Measurement of COPD’s impact using the COPD assessment test (CAT) and symptom assessment differences between patients and family members
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013

Clinical, functional and laboratory assessment of treatment efficacy in COPD patients
Source: International Congress 2014 – Predictors
Year: 2014


Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011

Health status measurement in COPD patients. Correlations with dyspnea and physiologic outcomes
Source: Eur Respir J 2005; 26: Suppl. 49, 515s
Year: 2005

Changes in COPD symptom control questionnaire (CCQ) scores after seven days of treatment with prednisolone of acute exacerbations in hospitalised patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 54s
Year: 2003

Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


LATE-BREAKING ABSTRACT: Intra-day symptoms fluctuations: STORICO, observational study on the characterization of 24-hour symptoms in COPD patients
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016


Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Peculiar properties of sleep structure and impact of antidepressive therapy in COPD patients with concomitant depressive episode
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013


Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014


Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study
Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence
Year: 2017

Impact of morning symptoms experienced by COPD patients on exacerbation risk, rescue inhaler usage and normal daily activities
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012


Comparison of COPD patients with high and low symptoms from a real-world US survey
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015